Ted Schwartz, a cancer survivor, gifted $15M to City of Hope that will be used entirely to further accelerate immunotherapy research and treatment innovations, such as the CAR T-cell therapy that saved his life.
In the evolving landscape of pediatric oncology, survivorship research has become an essential component of our mission to improve long-term patient outcomes. At City of Hope, we are focused on not only curing childhood cancers but also ensuring that survivors live the healthiest lives possible. A significant part of my research has been dedicated to mitigating the long-term toxicities of cancer therapy—particularly cardiovascular complications that can arise decades after treatment.
